Emphysema treatment
Pro Research Analysisby 
Searched over 200M research papers for "emphysema treatment"
Emphysema Treatment: Current Approaches and Efficacy
Spiration Valve System (SVS) for Severe Emphysema
The Spiration Valve System (SVS) has shown promise in treating severe heterogeneous emphysema. In a multicenter, randomized controlled trial, patients treated with SVS demonstrated significant improvements in lung function, specifically in forced expiratory volume in one second (FEV1), compared to those receiving only medical management. The treatment group also saw improvements in secondary outcomes such as target lobe volume reduction, hyperinflation, health status, and dyspnea, although there was a higher incidence of serious adverse events, primarily pneumothorax.
Lung Volume Reduction Coils (LVRCs)
Lung volume reduction coils (LVRCs) have been evaluated for their efficacy in patients with severe emphysema and hyperinflation. Studies indicate that LVRC treatment can significantly improve quality of life, as measured by the St George's Respiratory Questionnaire (SGRQ), and enhance lung function and exercise capacity. The safety profile of LVRCs is acceptable, with no significant difference in serious adverse events between the treatment and control groups .
Thermal Vapour Ablation
Thermal vapour ablation targets the more diseased segments of the lung, preserving healthier areas. This method has shown significant improvements in lung function and quality of life at six months post-treatment. The most common serious adverse event was COPD exacerbation, with one treatment-related death reported. Despite these risks, the targeted approach offers a clinically meaningful benefit for patients with severe emphysema.
All-Trans-Retinoic Acid (ATRA)
A pilot study explored the use of all-trans-retinoic acid (ATRA) for treating emphysema. While ATRA was well-tolerated, with only mild side effects, the study did not find significant improvements in physiological or imaging outcomes. Further research with higher doses or longer treatment durations may be necessary to evaluate its potential efficacy.
Endobronchial Valves (EBVs)
Endobronchial valves (EBVs) have been studied extensively for their role in lung volume reduction. In patients without interlobar collateral ventilation, EBV treatment significantly improved pulmonary function, exercise capacity, and quality of life. However, the treatment was associated with a higher incidence of serious adverse events, including pneumothorax and valve-related complications .
Lung Volume Reduction Surgery (LVRS)
Lung volume reduction surgery (LVRS) remains a viable option for certain patients with severe emphysema. The National Emphysema Treatment Trial (NETT) demonstrated that LVRS can improve survival, exercise capacity, and quality of life, particularly in patients with upper-lobe predominant emphysema and low exercise capacity. The benefits of LVRS are durable, with improvements observed up to five years post-surgery .
Conclusion
The treatment landscape for emphysema includes a variety of approaches, each with its own benefits and risks. Minimally invasive options like SVS, LVRCs, thermal vapour ablation, and EBVs offer significant improvements in lung function and quality of life, though they come with potential adverse events. LVRS remains a robust option for specific patient subgroups, providing long-term benefits. Ongoing research and clinical trials will continue to refine these treatments and explore new therapeutic avenues.
Sources and full results
Most relevant research papers on this topic